BioNTech SE is 4.5x more valuable than CG Oncology, Inc. by market capitalization ($21.79 B vs $4.84 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CGON | BNTX |
|---|---|---|
| Market cap | $4.84 B | $21.79 B |
| US-listed rank | #1405 | #587 |
| Net income (latest FY) | -$161.00M | - |
| SEC filings | 189 | 548 |
BioNTech SE is 4.5x more valuable than CG Oncology, Inc. by market capitalization ($21.79 B vs $4.84 B).
Full pages: CG Oncology, Inc. and BioNTech SE, or browse the full rankings.